BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19049941)

  • 1. Re-evaluation of CD34-negative dermatofibrosarcoma protuberans with a highly sensitive, tyramide-based immunohistochemical analysis.
    Nakanishi G; Suzuki N; Lin SN; Asagoe K; Iwatsuki K
    Eur J Dermatol; 2008; 18(6):719-21. PubMed ID: 19049941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Giant cell fibroblastoma associated with Darier-Ferrand dermatofibrosarcoma in an adult].
    Kourda M; Krichen H; Kennou H; Ben Yahia K; Ben Ayed M; Souissi R
    Ann Dermatol Venereol; 1998 Apr; 125(4):255-6. PubMed ID: 9747262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
    Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
    Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
    Wu JK; Malik MM; Egan CA
    Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of CD34 in the diagnosis of dermatofibrosarcoma protuberans].
    Santelli G; Zémoura L; Fain J; Venencie PY
    Ann Pathol; 1996; 16(2):149-50. PubMed ID: 8767688
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL; Cardona DM; Su Z; Puri PK
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatofibrosarcoma protuberans expresses CD34.
    Aiba S
    J Am Acad Dermatol; 1994 Mar; 30(3):508. PubMed ID: 7509354
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathology quiz case. Dermatofibrosarcoma protuberans (DFSP) of the scalp.
    Quintanilla-Dieck Mde L; Farrag TY; Micchelli S; Burkart A; Aygun N; Tufano RP
    Arch Otolaryngol Head Neck Surg; 2008 Aug; 134(8):897-8. PubMed ID: 18711068
    [No Abstract]   [Full Text] [Related]  

  • 12. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
    Tardío JC
    J Cutan Pathol; 2008 Dec; 35(12):1079-92. PubMed ID: 18976402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-headed nodules on the abdomen. Myxoid dermatofibrosarcoma protuberans (DFSP).
    Kunisada M; Nagai H; Shimizu H; Yogianti F; Nishiyama S; Nishigori C
    Arch Dermatol; 2011 Jul; 147(7):857-62. PubMed ID: 21768490
    [No Abstract]   [Full Text] [Related]  

  • 14. Subcutaneous dermatofibrosarcoma protuberans in skin of the breast: may mimic a primary breast lesion.
    Bulliard C; Murali R; Chang LY; Brennan ME; French J
    Pathology; 2007 Aug; 39(4):446-8. PubMed ID: 17676490
    [No Abstract]   [Full Text] [Related]  

  • 15. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
    McNiff JM; Subtil A; Cowper SE; Lazova R; Glusac EJ
    J Cutan Pathol; 2005 Jul; 32(6):413-8. PubMed ID: 15953374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans: clinicopathological aspects of an unusual cutaneous tumor.
    Korkolis DP; Liapakis IE; Vassilopoulos PP
    Anticancer Res; 2007; 27(3B):1631-4. PubMed ID: 17595787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma protuberans: ultrastructural and immunocytochemical observations.
    Dominguez-Malagón HR; Ordóñez NG; Mackay B
    Ultrastruct Pathol; 1995; 19(4):281-9. PubMed ID: 7571086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A tumor can hide another one].
    Chatelain D; Djian F; Vignon-Pennamen MD; Verola O; Champeau F; Servant JM; Janin A
    Ann Pathol; 1998 Dec; 18(6):503-4. PubMed ID: 10051920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.